SCHEMBL223830

SCHEMBL223830

O=Cc1ccc(-c2cccs2)s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.96
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 4/20 0.51
GAA P10253 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
GLA P06280 2/20 0.51
MAPT P10636 2/20 0.51
MEN1 O00255 2/20 0.51
POLB P06746 2/20 0.51
HPGD P15428 2/20 0.51
CASP1 P29466 2/20 0.51
CASP7 P55210 2/20 0.51
KMT2A Q03164 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HSD17B10 Q99714 2/20 0.51
USP2 O75604 1/20 0.51
THRB P10828 1/20 0.51
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51
ALOX12 P18054 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL498654 0.98 DPP4 (1.00) DPP4ALDH1A1KDM4EGAAL3MBTL1
SCHEMBL16081599 0.98 DPP4 (1.00) DPP4ALDH1A1KDM4EGAAL3MBTL1
SCHEMBL19721713 0.83 DPP4 (0.69) DPP4ALDH1A1KDM4EGAAL3MBTL1
SCHEMBL30375911 0.83 DPP4 (0.69) DPP4ALDH1A1KDM4EGAAL3MBTL1
SCHEMBL278904 0.82 DPP4 (0.65) DPP4ALDH1A1KDM4EGAAMAPT
SCHEMBL6876791 0.82 DPP4 (0.67) DPP4ALDH1A1KDM4EGAAL3MBTL1
SCHEMBL6876796 0.82 DPP4 (0.67) DPP4ALDH1A1KDM4EGAAL3MBTL1
SCHEMBL8010155 0.81 DPP4 (0.66) DPP4ALDH1A1KDM4EGAAL3MBTL1
SCHEMBL607254 0.80 DPP4 (0.69) DPP4ALDH1A1KDM4EGAAMAPT
SCHEMBL8827040 0.80 DPP4 (0.64) DPP4ALDH1A1KDM4EGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112645897-B Thiazole derivative and preparation method and application thereof 广东省微生物研究所(广东省微生物分析检测中心) 2022-05-24 CN claimed
CN-112645897-A Thiazole derivative and preparation method and application thereof 广东省微生物研究所(广东省微生物分析检测中心) 2021-04-13 CN claimed
CN-110240588-A Organic fluorescence materials and preparation method thereof and crystallite 首都师范大学 2019-09-17 CN claimed
CN-110240589-A Novel organic micromolecular photoelectric material micro-nano device preparation method 首都师范大学 2019-09-17 CN claimed
US-20170166691-A1 METAL CHALCOGENIDE NANOSTRUCTURES LELLOUCHE JEAN-PAUL (IL) 2017-06-15 US claimed
CN-100343256-C Biaryl substituted diazabicycloalkane amides as nicotinic acetylcholine agonists ASTRAZENECA AB (SE) 2007-10-17 CN claimed
CN-1678615-A Biaryl substituted diazabicycloalkanes as nicotinic acetylcholine antagonists ASTRAZENECA AB (SE) 2005-10-05 CN claimed
CN-121574125-A Selenium-containing aggregation-induced emission organic small molecular compound and application thereof in radioactive photodynamic therapy 大连理工大学 2026-02-27 CN disclosed
US-12435075-B2 Compound, film, sensor, and electronic device SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-10-07 US disclosed
WO-2025063197-A1 CRYSTAL, METHOD FOR PRODUCING CRYSTAL, AND METHOD FOR INDUCING SELF-ORGANIZATION OF SILANOL COMPOUND 国立研究開発法人産業技術総合研究所 2025-03-27 WO disclosed
CN-113195801-B Crystal, method for producing crystal, and method for self-assembling silanol compound 国立研究开发法人产业技术综合研究所 2024-10-15 CN disclosed
CN-118420606-A Fluorescent probe and application thereof in viscosity detection 天津理工大学 2024-08-02 CN disclosed
CN-116731006-B Thiazole aminoguanidine compound as well as preparation method and application thereof 广东省科学院微生物研究所(广东省微生物分析检测中心) 2024-04-02 CN disclosed
US-5185363-A Administering for treatment of inflammatory diseases ABBOTT LABORATORIES (US) 1993-02-09 US disclosed
US-5158598-A Insecticides, miticides, and nematocides; nonphytotoxic BASF AKTIENGESELLSCHAFT (DE) 1992-10-27 US disclosed
WO-1992001682-A1 ACETYLENE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LABORATORIES (US) 1992-02-06 WO disclosed
EP-0588785-A4 UREA BASED LIPOXYGENASE INHIBITING COMPOUNDS. ABBOTT LAB (US) 1991-12-30 EP disclosed
WO-1990012008-A1 UREA BASED LIPOXYGENASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1990-10-18 WO disclosed
EP-0353667-A1 Bithienyl derivatives, process for their preparation, and compositions containing them BASF Aktiengesellschaft (DE) 1990-02-07 EP disclosed
US-4861691-A Electrophotographic photosensitive material containing hydrazone compound FUJI ELECTRIC COMPANY, LTD. (JP) 1989-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170166691-A1 METAL CHALCOGENIDE NANOSTRUCTURES EPCAM, SOD1, DCX DPP4 3328/4885ALDH1A1 3190/4885KDM4E 4349/4885
US-12435075-B2 Compound, film, sensor, and electronic device HAX1, CYP19A1, ESR1 DPP4 4518/4885ALDH1A1 311/4885KDM4E 1429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.